Callan Family Office, LLC
Family OfficePosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1938970
RADNOR, PA
Position in ALNY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,004,190
-$432,917 QoQ
Shares Held
3,035
-16.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Callan Family Office, LLC holds $25,981,974 across 28 Biotechnology names. ALNY ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,036 | $6,981,575 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,262 | $6,815,093 | |
| 3 | GMAB |
Genmab A/S
|
55,047 | $1,476,911 | |
| 4 | ARGX |
Argenx SE
|
1,977 | $1,443,704 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
7,358 | $1,391,029 | |
| 6 | TECH |
BIO-TECHNE Corp
|
20,483 | $1,070,441 | |
| 7 | INCY |
Incyte Corp
|
11,135 | $1,048,026 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3,035 | $1,004,190 |
All Filings in ALNY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,004,190 | 3,035 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,437,107 | 3,614 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,256,736 | 2,756 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $955,769 | 2,931 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $274,880 | 1,018 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $245,193 | 1,042 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||